Stay updated on Belimumab in Lupus Nephritis Clinical Trial

Sign up to get notified when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Belimumab in Lupus Nephritis Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    Revision banner updated to v3.4.2. The previous funding-status notice (v3.4.1) has been removed.
    Difference
    0.2%
    Check dated 2026-02-11T09:18:27.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding notice regarding NIH operations status and updated the page revision to v3.4.1 (replacing v3.4.0). To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-04T05:21:32.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added Show glossary option and updated meta labels to 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0', replacing the previous labels. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-28T03:45:57.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Added Revision: v3.3.4 and removed 'Systemic lupus erythematosus' keyword with related topics ('MedlinePlus Genetics') and previous Revision: v3.3.3 from the page metadata. These updates do not alter study details, eligibility, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:01:22.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The Locations section was restructured by removing state-level location blocks (for example, California Locations, Florida Locations, New York Locations) and introducing a consolidated list of sites. The new list expands site coverage across the US, Canada, Argentina, Mexico, Brazil, Germany, China, Belgium, Hong Kong, and other regions.
    Difference
    2%
    Check dated 2025-12-23T09:27:04.000Z thumbnail image
  7. Check
    71 days ago
    Change Detected
    Summary
    Added reference: Anders HJ, Furie R, Malvar A, Zhao MH, Hiromura K, Weinmann-Menke J, Green Y, Jones-Leone A, Negrini D, Levy RA, Lightstone L, Tanaka Y, Rovin BH. Effect of belimumab on kidney-related outcomes in patients with lupus nephritis: post hoc subgroup analyses of the phase 3 BLISS-LN trial. Nephrol Dial Transplant. 2023 Nov 30;38(12):2733-2742.
    Difference
    0.0%
    Check dated 2025-12-16T03:16:43.000Z thumbnail image

Stay in the know with updates to Belimumab in Lupus Nephritis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Belimumab in Lupus Nephritis Clinical Trial page.